ID MEX3D_HUMAN Reviewed; 651 AA. AC Q86XN8; A0PJL8; A1L023; E9PAL6; Q71M49; DT 13-APR-2004, integrated into UniProtKB/Swiss-Prot. DT 20-MAR-2007, sequence version 3. DT 27-MAR-2024, entry version 167. DE RecName: Full=RNA-binding protein MEX3D; DE AltName: Full=RING finger and KH domain-containing protein 1; DE AltName: Full=RING finger protein 193; DE AltName: Full=TINO; GN Name=MEX3D; Synonyms=KIAA2031, RKHD1, RNF193; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY. RX PubMed=17267406; DOI=10.1093/nar/gkm016; RA Buchet-Poyau K., Courchet J., Le Hir H., Seraphin B., Scoazec J.-Y., RA Duret L., Domon-Dell C., Freund J.-N., Billaud M.; RT "Identification and characterization of human Mex-3 proteins, a novel RT family of evolutionarily conserved RNA-binding proteins differentially RT localized to processing bodies."; RL Nucleic Acids Res. 35:1289-1300(2007). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15057824; DOI=10.1038/nature02399; RA Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E., RA Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A., RA Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S., RA Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A., RA Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J., RA Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M., RA Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W., RA Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V., RA Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D., RA McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I., RA Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L., RA Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., RA She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., RA Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., RA Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E., RA Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M., RA Rubin E.M., Lucas S.M.; RT "The DNA sequence and biology of human chromosome 19."; RL Nature 428:529-535(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 137-651 (ISOFORM 1). RC TISSUE=Brain; RA Nagase T., Kikuno R., Ohara O.; RT "The nucleotide sequence of a long cDNA clone isolated from human."; RL Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [MRNA] OF 177-651 (ISOFORM 2). RC TISSUE=Placenta; RX PubMed=14769789; DOI=10.1074/jbc.m314071200; RA Donnini M., Lapucci A., Papucci L., Witort E., Jacquier A., Brewer G., RA Nicolin A., Capaccioli S., Schiavone N.; RT "Identification of TINO: a new evolutionarily conserved BCL-2 AU-rich RT element RNA-binding protein."; RL J. Biol. Chem. 279:20154-20166(2004). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 178-651 (ISOFORM 2). RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-510 AND SER-514, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=23186163; DOI=10.1021/pr300630k; RA Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J., RA Mohammed S.; RT "Toward a comprehensive characterization of a human cancer cell RT phosphoproteome."; RL J. Proteome Res. 12:260-271(2013). RN [7] RP STRUCTURE BY NMR OF 272-343. RG RIKEN structural genomics initiative (RSGI); RT "Solution structure of the second KH domain in RING finger and KH domain- RT containing protein 1."; RL Submitted (SEP-2006) to the PDB data bank. CC -!- FUNCTION: RNA binding protein, may be involved in post-transcriptional CC regulatory mechanisms. {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}. CC Note=Predominantly expressed in the cytoplasm and shuttles between the CC cytoplasm and the nucleus through the CRM1 export pathway. CC {ECO:0000250}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=3; CC Name=1; CC IsoId=Q86XN8-1; Sequence=Displayed; CC Name=2; Synonyms=TINO; CC IsoId=Q86XN8-2; Sequence=VSP_024019; CC Name=3; CC IsoId=Q86XN8-3; Sequence=VSP_047662; CC -!- TISSUE SPECIFICITY: Ubiquitously expressed in all the cell lines and CC tissues tested. {ECO:0000269|PubMed:17267406}. CC -!- DOMAIN: Binds RNA through its KH domains. {ECO:0000250}. CC -!- PTM: Phosphorylated. {ECO:0000250}. CC -!- SEQUENCE CAUTION: CC Sequence=AAQ04763.1; Type=Erroneous initiation; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AY950680; AAY34148.1; -; mRNA. DR EMBL; AC005943; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC027307; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AB107353; BAC67658.1; -; mRNA. DR EMBL; AF458084; AAQ04763.1; ALT_INIT; mRNA. DR EMBL; BC113384; AAI13385.1; -; mRNA. DR EMBL; BC113741; AAI13742.2; -; mRNA. DR CCDS; CCDS32865.2; -. [Q86XN8-1] DR RefSeq; NP_001167589.1; NM_001174118.1. [Q86XN8-3] DR RefSeq; NP_976049.3; NM_203304.3. [Q86XN8-1] DR PDB; 2DGR; NMR; -; A=272-341. DR PDBsum; 2DGR; -. DR AlphaFoldDB; Q86XN8; -. DR SMR; Q86XN8; -. DR BioGRID; 134376; 48. DR IntAct; Q86XN8; 11. DR STRING; 9606.ENSP00000384398; -. DR GlyGen; Q86XN8; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; Q86XN8; -. DR PhosphoSitePlus; Q86XN8; -. DR BioMuta; MEX3D; -. DR DMDM; 134047829; -. DR EPD; Q86XN8; -. DR jPOST; Q86XN8; -. DR MassIVE; Q86XN8; -. DR MaxQB; Q86XN8; -. DR PaxDb; 9606-ENSP00000384398; -. DR PeptideAtlas; Q86XN8; -. DR ProteomicsDB; 19040; -. DR ProteomicsDB; 70305; -. [Q86XN8-1] DR ProteomicsDB; 70306; -. [Q86XN8-2] DR Pumba; Q86XN8; -. DR Antibodypedia; 22752; 61 antibodies from 21 providers. DR DNASU; 399664; -. DR Ensembl; ENST00000402693.5; ENSP00000384398.3; ENSG00000181588.17. [Q86XN8-1] DR GeneID; 399664; -. DR KEGG; hsa:399664; -. DR MANE-Select; ENST00000402693.5; ENSP00000384398.3; NM_203304.4; NP_976049.3. DR UCSC; uc060rdi.1; human. [Q86XN8-1] DR AGR; HGNC:16734; -. DR CTD; 399664; -. DR DisGeNET; 399664; -. DR GeneCards; MEX3D; -. DR HGNC; HGNC:16734; MEX3D. DR HPA; ENSG00000181588; Tissue enriched (testis). DR MIM; 611009; gene. DR neXtProt; NX_Q86XN8; -. DR OpenTargets; ENSG00000181588; -. DR PharmGKB; PA162395829; -. DR VEuPathDB; HostDB:ENSG00000181588; -. DR eggNOG; KOG2113; Eukaryota. DR GeneTree; ENSGT00940000162613; -. DR HOGENOM; CLU_025598_2_1_1; -. DR InParanoid; Q86XN8; -. DR OMA; PFERSGN; -. DR OrthoDB; 50983at2759; -. DR PhylomeDB; Q86XN8; -. DR TreeFam; TF315107; -. DR PathwayCommons; Q86XN8; -. DR SignaLink; Q86XN8; -. DR SIGNOR; Q86XN8; -. DR BioGRID-ORCS; 399664; 9 hits in 1194 CRISPR screens. DR EvolutionaryTrace; Q86XN8; -. DR GeneWiki; MEX3D; -. DR GenomeRNAi; 399664; -. DR Pharos; Q86XN8; Tdark. DR PRO; PR:Q86XN8; -. DR Proteomes; UP000005640; Chromosome 19. DR RNAct; Q86XN8; Protein. DR Bgee; ENSG00000181588; Expressed in right testis and 120 other cell types or tissues. DR ExpressionAtlas; Q86XN8; baseline and differential. DR GO; GO:0005634; C:nucleus; IDA:BHF-UCL. DR GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:BHF-UCL. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0035925; F:mRNA 3'-UTR AU-rich region binding; IDA:BHF-UCL. DR GO; GO:0003723; F:RNA binding; HDA:UniProtKB. DR GO; GO:0061157; P:mRNA destabilization; NAS:BHF-UCL. DR GO; GO:0010609; P:mRNA localization resulting in post-transcriptional regulation of gene expression; NAS:BHF-UCL. DR CDD; cd22423; KH-I_MEX3_rpt1; 1. DR CDD; cd22424; KH-I_MEX3_rpt2; 1. DR Gene3D; 3.30.1370.10; K Homology domain, type 1; 2. DR Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1. DR InterPro; IPR047228; KH-I_MEX3_rpt1. DR InterPro; IPR047226; KH-I_MEX3_rpt2. DR InterPro; IPR004087; KH_dom. DR InterPro; IPR004088; KH_dom_type_1. DR InterPro; IPR036612; KH_dom_type_1_sf. DR InterPro; IPR047227; MEX3. DR InterPro; IPR001841; Znf_RING. DR InterPro; IPR013083; Znf_RING/FYVE/PHD. DR PANTHER; PTHR23285; RING FINGER AND KH DOMAIN CONTAINING PROTEIN 1; 1. DR PANTHER; PTHR23285:SF3; RNA-BINDING PROTEIN MEX3D; 1. DR Pfam; PF00013; KH_1; 2. DR Pfam; PF13920; zf-C3HC4_3; 1. DR SMART; SM00322; KH; 2. DR SUPFAM; SSF54791; Eukaryotic type KH-domain (KH-domain type I); 2. DR SUPFAM; SSF57850; RING/U-box; 1. DR PROSITE; PS50084; KH_TYPE_1; 2. DR PROSITE; PS50089; ZF_RING_2; 1. DR Genevisible; Q86XN8; HS. PE 1: Evidence at protein level; KW 3D-structure; Alternative splicing; Cytoplasm; Metal-binding; Nucleus; KW Phosphoprotein; Reference proteome; Repeat; RNA-binding; Zinc; Zinc-finger. FT CHAIN 1..651 FT /note="RNA-binding protein MEX3D" FT /id="PRO_0000050123" FT DOMAIN 179..240 FT /note="KH 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00117" FT DOMAIN 273..334 FT /note="KH 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00117" FT ZN_FING 600..640 FT /note="RING-type" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00175" FT REGION 1..159 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 375..394 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 401..443 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 495..531 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 28..53 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 127..148 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 510 FT /note="Phosphothreonine" FT /evidence="ECO:0007744|PubMed:23186163" FT MOD_RES 514 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:23186163" FT VAR_SEQ 648..651 FT /note="HIFS -> RVETPQPGGASALQRQY (in isoform 2)" FT /evidence="ECO:0000303|PubMed:14769789, FT ECO:0000303|PubMed:15489334" FT /id="VSP_024019" FT VAR_SEQ 648..651 FT /note="HIFS -> RVETETPQPGGASALQRQY (in isoform 3)" FT /evidence="ECO:0000305" FT /id="VSP_047662" FT STRAND 273..279 FT /evidence="ECO:0007829|PDB:2DGR" FT HELIX 282..289 FT /evidence="ECO:0007829|PDB:2DGR" FT TURN 290..293 FT /evidence="ECO:0007829|PDB:2DGR" FT HELIX 296..302 FT /evidence="ECO:0007829|PDB:2DGR" FT STRAND 306..308 FT /evidence="ECO:0007829|PDB:2DGR" FT STRAND 312..314 FT /evidence="ECO:0007829|PDB:2DGR" FT STRAND 317..322 FT /evidence="ECO:0007829|PDB:2DGR" FT TURN 324..326 FT /evidence="ECO:0007829|PDB:2DGR" FT HELIX 327..339 FT /evidence="ECO:0007829|PDB:2DGR" SQ SEQUENCE 651 AA; 64883 MW; 5E056EE2D08BC4CD CRC64; MPSSLGQPDG GGGGGGGGGG VGAAGEDPGP GPAPPPEGAQ EAAPAPRPPP EPDDAAAALR LALDQLSALG LGGAGDTDEE GAAGDGAAAA GGADGGAAPE PVPPDGPEAG APPTLAPAVA PGSLPLLDPN ASPPPPPPPR PSPPDVFAGF APHPAALGPP TLLADQMSVI GSRKKSVNMT ECVPVPSSEH VAEIVGRQGC KIKALRAKTN TYIKTPVRGE EPVFIVTGRK EDVEMAKREI LSAAEHFSII RATRSKAGGL PGAAQGPPNL PGQTTIQVRV PYRVVGLVVG PKGATIKRIQ QRTHTYIVTP GRDKEPVFAV TGMPENVDRA REEIEAHITL RTGAFTDAGP DSDFHANGTD VCLDLLGAAA SLWAKTPNQG RRPPTATAGL RGDTALGAPS APEAFYAGSR GGPSVPDPGP ASPYSGSGNG GFAFGAEGPG APVGTAAPDD CDFGFDFDFL ALDLTVPAAA TIWAPFERAA PLPAFSGCST VNGAPGPPAA GARRSSGAGT PRHSPTLPEP GGLRLELPLS RRGAPDPVGA LSWRPPQGPV SFPGGAAFST ATSLPSSPAA AACAPLDSGA SENSRKPPSA SSAPALAREC VVCAEGEVMA ALVPCGHNLF CMDCAVRICG KSEPECPACR TPATQAIHIF S //